Close this search box.

made visible

Innovation indicators for data-driven performance

The companies at Pivot Park focus on drug development. Specifically, on immuno-oncology and technological know-how for the production of medicines. But how good are we at supporting them? What’s working well? What could be improved? What looks like a dead end?

We believe that the answer lies in using data to drive performance. By mapping networks, collaborations, finance attracted and patents registered, we can visualise what we and our tenants are doing – and use this innovation dashboard to further boost our combined innovative capacity.

We consider the following factors to be the most important innovation indicators. We then use these indicators to take targeted, data-based steps to continuously boost innovation at Pivot Park.

Networks and collaborations

This map shows collaborations and networks that include Pivot Park. Examples include collaborations on scientific publications or patents, agreed financing deals and other collaboration projects involving internal and external companies.

Triple Helix

Collaborations at Pivot Park involving universities, the government and our tenant companies that aim to stimulate knowledge exchange.

Secured financing

The financing secured by companies at Pivot Park. This includes both financing by investors and subsidies or credits provided by government institutions and other bodies or organisations.

Patents and publications

Scientific publications and patents that have resulted from funding.

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?


The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.